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Abstract – Scabies is a major threat to the well being of mountain-dwelling Bovid hosts, Rupicapra
rupicapra and Rupicapra pyrenaica. Severe outbreaks are in progress over a significant part of their
distribution area and resource managers demand improved methods to monitor, analyse and
possibly forecast the spread and effects of scabies at the population level. An amplified capture
enzyme-linked immunosorbent assay was developed to detect antibodies to Sarcoptes scabiei in
chamois (Rupicapra spp.) serum. The method used the biotin-avidin amplification system and was
validated on a panel of 144 serum samples, of which 40 were obtained from scabietic and 104 from
healthy unexposed individuals originating from a scabies-free area. The antigen, a whole body
extract of the various developmental stages of S. scabiei, was prepared from mites actively leaving
the skin lesions of naturally infested red foxes (Vulpes vulpes). The resulting LAB-ELISA was
characterised by 93% sensitivity, 97% specificity and a high degree of repeatibility. A single
seroreactor was found amongst 32 chamois affected with skin pathologies other than scabies,
including infestations by other Acarina (Trombicula spp. and Ixodid ticks). Antibodies to S. scabiei
were present in 26 out of 169 sera (15.4%) obtained by clinically healthy chamois within a scabies
outbreak area, indicating that asymptomatic infestations by S. scabiei can be revealed by serological
methods in the studied Caprinae hosts.
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1. INTRODUCTION 
Scabies is a contagious skin disease caused
by the mite Sarcoptes scabiei. Man, domes-
tic animals and several captive and free-
ranging wildlife are affected worldwide [31].
Wild Caprinae are particularly sensitive to
Sarcoptes infestation and severe outbreaks
of a generalised form of crusty scabies have
been reported in chamois (Rupicapra rupi-
capra rupicapra and Rupicapra pyrenaica
parva) and ibex (Capra ibex ibex and Capra
pyrenayca) in southern Europe [15, 24, 33].
Effects on the population are obvious, in
fact crude mortality exceeds 90% on occa-
sions [24, 33]. This is a matter of concern
for local authorities and resource managers
and there is a demand for careful monitor-
ing of the spread and severity of the out-
breaks as well as, possibly, forecasting
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future scenarios. Despite considerable effort
by wildlife veterinarians, biologists and field
personnel, monitoring scabies outbreaks by
means of current methods of investigation
(active search for carcasses, observation from
distance, direct counts) is a time-consuming,
difficult and somewhat indefinite task because
of environmental conditions and problems
associated with sampling and identifying
mite-infested free-ranging animals [28].
In 1991, Boyce et al. [12] showed that
antibodies to Psoroptes spp. may be detected
in naturally and experimentally infested
bighorn sheep (Ovis canadensis) by means
of a kinetic immunosorbent assay. The test
was subsequently used to determine the dis-
tribution of mite-exposed bighorn sheep
herds in California [26]. The aim of the
screening was to avoid accidental spreading
of psoroptic scabies during active reloca-
tion programmes. Based on the above expe-
riences, a new serological test – a labelled
avidin-biotin immunosorbent assay (LAB-
ELISA) – was developed as an aid to epide-
miological and pathogenetic studies of Sar-
coptes scabies in wild Caprinae in southern
Europe. 
2. MATERIALS AND METHODS
2.1. Antigen
Living S. scabiei mites at different stages
of development and of both sexes were col-
lected from the crusty lesions of naturally
infested red foxes (Vulpes vulpes), accord-
ing to Fisher [17]. Mites were transferred to
Eppendorf tubes and stored at –20 °C until
required. 
Mite samples were thawed and washed
in 0.1 M carbonate buffer pH 7.2 (Na2 CO3
0.1 M 33%, Na2HCO3 0.1 M 67%) contain-
ing 1:1000 Tween 20 to eliminate inciden-
tal impurity. Then they were filtered out, air
dried and weighed. Aliquots of 20 mg mites
were homogenised at room temperature in
a Griffiths tube with 0.1 M carbonate buffer
pH 9.6 and subsequently sonicated five
times for 30 s. The ratio of mites to saline in
this preparation was approximately 10 mg/
15 mL. The suspension was stirred at 4 °C
for 16 h and the supernatant was harvested
after centrifugation at 18 000 g for 30 min. 
The soluble extract was filtered at 0.2 µm
and the protein concentration, determined
by the Lowry method, was adjusted to a con-
centration of 200 µg/mL in 0.1 M carbonate
buffer pH 9.6. The antigen was stored at
–30 °C in 1 mL aliquots.
2.2. Chamois sera
Serum samples, obtained from 5 scabietic
plus skin-scraping positive chamois from a
longtime scabies-endemic area (Eastern
Alps, Italy) and 5 healthy unexposed cham-
ois from a scabies-free area (Western Alps,
Italy), were initially used to determine opti-
mal assay conditions. According to the repeat-
ability estimate, these sera were later used
as control samples during routine runs of
the assay.
Once assay conditions were established,
104 sera collected from healthy unexposed
chamois (Western Alps, Italy) were used as
the negative panel, and 40 sera from scabi-
etic plus skin-scraping positive chamois
(21 from the Eastern Alps, Italy, and 19
from the Cordillera Cantabrica, Spain)
were used as the positive panel. Out of the
scabietic chamois, 14 were mildly affected
(less than 10% of the skin surface showing
alopecia and focal hyperkeratotic areas), 18
were moderately affected (diffuse hyperk-
eratosis and localised thick crusts over 10–
25% of the skin surface) and 8 were
severely affected (thick fissured crusts over
up to 40% of the skin surface). Sera were
obtained also from: (i) 32 chamois from
scabies-free zones (Western Alps, Italy),
showing patent infections of one or more
of the following skin pathogens: chiggers
(Trombicula spp.; N = 12), Ixodid ticks
(Ixodes ricinus and/or Dermacentor mar-
ginatus; 15), biting lice (Damalinia alpina;
16), keds (Melophagus rupicaprae; 4), Tri-
chophyton verrucosum (2), Dermatophilus
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congolensis (1) and the Contagious Ecthima
virus (3); (ii) 169 healthy chamois from a
scabies outbreak area in Auronzo di Cadore
(Eastern Alps, Italy). For the sake of brev-
ity, the last ones will be lately cited as
“healthy exposed”. 
Blood was collected from the heart of
246 culled animals (40 healthy unexposed,
25 scabietic, 12 affected with other skin
pathologies, 169 healthy exposed); and from
the jugular vein of 99 animals (15 scabietic,
64 healthy unexposed, 20 affected with other
skin pathologies) captured either chemi-
cally or physically using drive nets. After
clotting, blood samples were centrifuged at
200 g for 15 min and sera were stored at
–20 °C in 1 mL aliquots until required. 
2.3. ELISA method
A 100 µL aliquot of the antigen was
added to each well of a microtiter plate
(TPP® Gamma sterilized), except for the first
column where 100 µL of carbonate buffer
pH 9.6 were added. The plate was left for
40 min at 37 °C, and subsequently at 4 °C
overnight. Coated like this, the plate was
stable for 8 h at 4 °C; otherwise the plate,
incubated for 1 h in PBS containing 3%
Bovine Serum Albumin and 0.01% Thio-
merosal and stored at 4 °C, is stable for a
week. 
Each coated well was washed five times
in phosphate buffer pH 7.2 containing
0.05% Tween 20 (SAF-T: NaH2 PO4·H2O
0.18%, Na2HPO4 1.24%, NaCl 0.85%,
Tween 20 0.05%). A 100 µL aliquot of
serum diluted 1:100 in SAF-T containing
2.0% Bovine Serum Albumin was added to
each well; the plate was then shaken for 1 h
at 37 °C on a Bellco Mini-Orbital Shaker
(Bellco Glass Inc., Vineland, NJ, USA).
After five additional washings in SAF-T,
100 µL of biotinylated Protein G (Immu-
nopure® Biotinylated Protein G, Pierce
Chemical Co., Rockford, IL, USA) diluted
1:1000 in sodium acetate buffer 0.1 M,
pH 5.0 (C2H3O2Na·3H2O 1.4%) was added.
The plate was again left one hour at 37 °C,
and then washed three times in SAF-T.
A 100 µL aliquot of horseradish-perox-
idase-labelled Avidin (Immunopure® Avi-
din Horseradish Peroxidase Conjugated,
Pierce Chemical Co., Rockford, IL, USA)
diluted 1:10 000 in phosphate buffer con-
taining 0.01% gelatine pH 7.2 was added to
each well, and incubated for one hour and
washed as before. The plate was washed
one time in citrate buffer 0.4 M before the
addition of 100 µL of substrate solution
[2 mM H2O2 0.2 M ABTS (2,2’-diazino
(3 ethilbenz-thiazoline-6-sulfonate), Sigma-
Aldrich Co., St. Louis, MO, USA) 0.4 M
citrate pH 4.0] to each well. The plate was
then incubated for 30 min at room temper-
ature.
Optical density was read at 405 nm with
a spectrophotometer (Anthos 2010, Anthos
Labtec Instruments, Wals, Austria).
2.4. Performance criteria of the assay
Assay results were expressed as Optical
Density (OD) percentage obtained by the
Percent Positivity (PP) method [21, 35],
where the OD of each sample tested is
expressed as a percentage of a high positive
reference standard. This relative measure-
ment results in a uniform and continuous
scale of 0–100 percent positivity, calcu-
lated according to the following formula:
OD percentage: OD (×) – OD (–) / OD (+)
– OD (–).
Each sample was assayed in triplicate, to
obtain a mean Vmax value; because multiple
plates were used, Vmax values on each plate
were multiplied by a correction factor, so
that between plates comparisons were valid
[34]. A correction factor was determined by
the following formula: Correction Factor:
mean Vmax of SPCS across plates / mean
Vmax of SPCS within a given plate, where
SPCS means the strong positive control
sera.
The intra-plate variability (CV1) was esti-
mated by testing the control samples 10 times
in triplicate within a particular plate; inter-
plate variability (CV2), was assessed by
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comparing the results of the same control
samples in five separated assays.
Repeatability was also determined by cal-
culating the amount of agreement using dif-
ferent batches of antigen.
Determination of the cut-off between the
positive and negative samples was achieved
using the VIFD (Visual Inspection of Fre-
quency Distributions) method, based on
frequency distributions of normalised test
results from the two panels of samples, pos-
itives and negatives. The cut-off value was
set at the intersection of the results of the
two distributions [20, 27]. 
The sensitivity and specificity of the assay
were calculated according to the following
formulae: Sensitivity: True Positive × 100 /
True Positive + False Negative; Specificity:
True Negative × 100 / True Negative + False
Positive.
3. RESULTS
The distribution of the LAB-ELISA OD
values for the sera examined is reported in
Table I. Values from the scabietic chamois
were significantly higher than those from
the healthy unexposed chamois (74.3 ± 13.6
vs. 27.3 ± 13.4; t = 8.96, P < 0.001, Mann-
Whitney U-test). No difference occurred
between the sera of 40 chamois allocated to
three classes based on scabies severity (H =
11.59; P = 0.48, Kruskall-Wallis test). 
The cut-off value of the test, found at the
intersection of the frequency distributions
of sera ODs from healthy unexposed and
scabietic chamois, was 55% (Fig. 1). Based
on the selected cut-off, 101 of the 104 sera
collected from healthy unexposed chamois
had negative OD values (true negatives)
and 3 showed positive OD values (false
positives); 37 of the 40 sera from scabietic
plus skin-scraping positive chamois had
positive OD values (true positives) and 3
showed negative OD values (false nega-
tives). The resulting sensitivity was 93%
and the specificity 97%. 
A high degree of repeatability was indi-
cated by CV1 = 10% for triplicate within
plates, and a CV2 = 5.8% for SPCS Vmax
across the plates. Correction factors derived
from the SPCS values varied from 0.91 to
1.09.
A single seroreactor was found amongst
the 32 chamois affected with skin patholo-
gies other than scabies (a chiggers infested
Table I. Distribution of the % OD values of sera obtained from 345 chamois (Rupicapra rupicapra
and Rupicapra pyrenaica). The examined cohorts were: healthy unexposed, originating from scabies-
free areas (N = 104); scabietic (40), grouped in three classes according to the severity of skin lesions
(mildly affected = less than 10% of the skin showing alopecia and focal hyperkeratotic areas;
moderately affected = diffuse hyperkeratosis and localized thick crusts over 10–25% of the skin;
severely affected = thick fissured crusts over up to 40% of the skin); affected with skin pathologies
other than scabies (32); healthy exposed, originating from a scabies outbreak area (169). 
%OD 0–10 11–20 21–30 31–40 41–50 51–60 61–70 71–80 81–90 91–100 101–110
Healthy unexposed 7 25 31 25 10 3 1 2 0 0 0
Scabietic 0 0 0 0 2 3 8 12 11 1 1
Mildly affected 1 2 1 6 4
Moderately affected 1 2 6 3 4 2
Severily affected 1 3 3 0 1
Skin diseases other 
than scabies
2 8 10 8 3 1 0 0 0 0 0
Healthy exposed 14 40 33 30 21 10 9 5 5 1 1
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female, which showed a 59% OD value).
OD values from this cohort were similar as
those from healthy unexposed ones (26.4 ±
12.5 vs. 27.3 ± 13.4; z = 0.455, P = 0.649,
Mann-Whitney U-test). 
A relatively high number of seroreactors
was found amongst healthy exposed cham-
ois (26 out of 169; 15.4%). The prevalence
of seroreactors significantly differed between
these chamois, the healthy unexposed ones
and those affected with skin pathologies
other than scabies (  = 13.16; P = 0.001,
Chi-square test). OD values from healthy
exposed chamois were higher (33.0 ± 21.4)
than values from any of the above two
cohorts of unexposed individuals but the
difference was not significant. 
4. DISCUSSION
Antibody responses to S. scabiei infes-
tation have been documented in domestic
and wildlife hosts [1, 3, 8] and standardised
immunosorbent assays are currently avail-
able for diagnosis and monitoring of sca-
bies in dogs and swine [9, 10, 19]. To the
best of our knowledge, the LAB-ELISA
described here is the first immunosorbent
assay designed for the detection of specific
antibodies against S. scabiei in a free-rang-
ing ruminant host.
A recognised problem when evaluating
a serological test is the availability of one
or more gold standards with which to com-
pare the results of the test. This aspect is
particularly delicate in the case of dogs and
swine, which are prone to develop a hyper-
sentive form of scabies where large mite
populations are unlikely to occur [13, 29].
Besides a limited proportion of mite posi-
tive individuals, in the above hosts, posi-
tives are a heterogeneous group comprising
either dogs positively responding to spe-
cific treatment [10] or pigs derived from
infected farms [19]. 
In the present study, the positive (infested)
and negative (unexposed) status of chamois
was objectively reliable. All positives were
represented by scabietic chamois testing
positive to S. scabiei at the skin scraping.
χ2
Figure 1. Frequency distribution of % Optical Density (OD) of sera obtained from scabietic
(positive) and healthy unexposed (negative) chamois. The Y-axis represents the number of sera in
each 5% OD interval on the X-axis. The grey line refers to negative sera and the black line to
positive sera (3-observations moving average). The broken line represents the cut-off value (55%)
selected from data analysis.
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Negatives were healthy individuals cap-
tured in recognised scabies-free zones of
northern Italy, some 450 km west of the
closest focus of chamois scabies. It is worth
stressing that scabies has a dramatic epi-
demic course in previously unexposed cham-
ois populations [33]; therefore, there is no
chance that such a condition may long
remain undetected in a host which is of the
outmost interest for thousands of mountain
hikers and sport hunters across alpine Europe.
Similarly to Bornstein and Wallgreen
[9], the whole body extract of mites obtained
from naturally infested red foxes proved a
suitable source of antigen. Scabies mites
from different host species are morpholog-
ically indistinguishable and S. scabiei is
generally recognised as a unique species
split into physiological varieties, adapted to
groups of zoologically related host species
[14, 30]. Close similarity between Sar-
coptes strains from nine host species (alpine
chamois and red fox included) has been
confirmed by means of molecular analyses
[5, 36]. Similarly, immunologic cross-reac-
tivity among various strains of scabies
mites (var. hominis, canis and suis) has
been demonstrated [4]. Scabies is relatively
common in red foxes throughout Italy and
thousands of mites may be isolated from an
individual with generalised crusty lesions.
This situation presented us the opportunity
to access sufficient quantities of mites for
antigen preparation and stock.
The use of recombinant protein G allowed
to overcome the problem of unavailable
commercial antisera to our target wild hosts.
Previously, recombinant protein G proved
a valuable alternative to secondary anti-
body in a kinetic ELISA developed for diag-
nosis of Psoroptes infestation in wild rumi-
nant hosts, Ovis canadensis, Ovis dalli and
Cervus canadensis [11, 12, 37].
The avidin-biotin detection system has
the potential to increase the sensitivity of
the indirect ELISA since avidin has four
binding sites for biotin, making an essen-
tially irreversible complex which is stable
in later washes and incubations [22]. We
ignore if and how the amplification afforded
by the avidin-biotin detection system is cru-
cial to the performance of a Sarcoptes-
ELISA working with serum samples but the
original decision to include this detection
system derived from: (i) the relatively low
sensitivity shown by a previously validated
non-amplified indirect ELISA, when checked
in a group of 94 certified Sarcoptes-
infected pigs [19]; (ii) the perspective of an
application of our test to the measurement
of lower specific IgG levels in fluids such
as the lung extract, which is more easily
available than serum of adequate quality in
free-ranging wildlife [16]. 
Other expected advantages of the avidin-
biotin detection system are the low back-
ground absorbance and the significant sav-
ing of specific antibody or protein G [18].
The choice to select a cut-off by means
of the VIFD method is an important element
for the adaptation of the assay according to
epidemiological requirements; depending on
epidemiological purposes – estimating the
prevalence of a disease, determining if
selected herds have been exposed, assess-
ing the risk of disease transmission between
wildlife and domestic hosts, etc. – it may be
more important to stress specificity rather
than sensitivity, or vice versa, and conse-
quently minimise the number of false pos-
itives or false negatives. Compared with
other methods, such as the receiver-opera-
tor characteristic (ROC) curve, VIFD has
the advantage of being simple and flexible,
and requires no statistical calculations or
assumptions about the normality of the dis-
tributions of infected and uninfected refer-
ence samples [21]. 
Overall, the LAB-ELISA permitted a
clear definition of the scabies infestation
status in chamois. Besides good sensitivity
leading to correct identification of even
mildly scabietic individuals, a high specif-
icity was demonstrated with samples from
a reliable scabies-free area and samples
from chamois affected with a variety of skin
pathologies which have to be considered in
differential diagnosis of scabies. Although
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sera from S. scabiei infested humans and
domestic animals are known to cross-react
with antigens of other mites, such as the
house dust mite Dermatophagoides ptero-
nyssinus [2], our data did not support evi-
dence of cross-reaction with Trombicula
spp., which frequently causes skin damage
to chamois and other wild ruminants in
Europe [6]. 
Remarkably, specific antibodies could
be detected in healthy exposed chamois, sug-
gesting that asymptomatic scabies infesta-
tion in this ruminant host can be revealed by
the studied ELISA. In other animal models,
the presence of asymptomatic seroreactors
has been associated to the incubation phase
[7], the subclinical course of the infestation
[10] or the persistence of antibodies after
therapy [23, 25]. As regards ruminants, per-
sistence of specific antibodies for more than
two months after successful treatment with
a macrocyclic lactone has been demon-
strated in cattle [32]. The possibility to reveal
a S. scabiei infestation status in asympto-
matic chamois is of a great interest for pro-
spective and retrospective studies assessing
the distribution and prevalence of S. scabiei
infestations in this host and other related
wild ruminants suffering from epidemic
scabies.
Work is continuing in chamois to ascer-
tain the following: (i) how frequently are
specific antibodies detectable in subclinical
infestations, involving small numbers of
mites; (ii) how soon after exposure are spe-
cific antibodies detectable in serum; (iii) how
long do antibodies persist in this or related
hosts after the disease has eventually self
cured or been cured. Information on these
factors will be necessary to assess the full
potential of the test. 
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